BRCA1: Cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution

Nucleic Acids Research

Volumn 34, Issue 5, 2006, Pages 1416-1426

  Deng, Chu Xia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; AURORA A KINASE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; FAS ANTIGEN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL MUTANT; CELL PROLIFERATION; CENTROSOME; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENETIC PREDISPOSITION; GENOMIC INSTABILITY; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; BREAST TUMOR; CELL CYCLE; CELL TRANSFORMATION; FEMALE; GENETICS; MOUSE; MUTATION; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; FEMALE; GENES, BRCA1; GENOMIC INSTABILITY; HUMANS; MICE; MUTATION;

EID: 33645003172     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl010     Document Type: Article

References (116)

1. Zhang,J. and Powell,S.N. (2005) The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol. Cancer Res., 3, 531-539.
2. Alberg,A.J., Lam,A.P. and Helzlsouer,K.J. (1999) Epidemiology, prevention, and early detection of breast cancer. Curr. Opin. Oncol., 11, 435-441.
3. Brody,L.C. and Biesecker,B.B. (1998) Breast cancer susceptibility genes. BRCA1 and BRCA2. Medicine (Baltimore), 77, 208-226.
4. Eccles,D.M. and Pichert,G. (2005) Familial non-BRCA1/BRCA2-associated breast cancer. Lancet Oncol., 6, 705-711.
5. Hall,J.M., Lee,M.K., Newman,B., Morrow,J.E., Anderson,L.A., Huey,B. and King,M.C. (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250, 1684-1689.
6. Miki,T., Bottaro,D.P., Fleming,T.P., Smith,C.L., Burgess,W.H., Chan,A.M. and Aaronson,S.A. (1992) Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc. Natl Acad. Sci. USA, 89, 246-250.
7. Easton,D.F., Ford,D. and Bishop,D.T. (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. Am. J. Hum. Genet., 56, 265-271.
8. Struewing,J.P., Hartge,P., Wacholder,S., Baker,S.M., Berlin,M., McAdams,M., Timmerman,M.M., Brody,L.C. and Tucker,M.A. (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl. J. Med., 336, 1401-1408.
9. Ford,D., Easton,D.F., Stratton,M., Narod,S., Goldgar,D., Devilee,P., Bishop,D.T., Weber,B., Lenoir,G., Chang-Claude,J. et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am. J. Hum. Genet., 62, 676-689.
10. Miki,Y., Swensen,J., Shattuck-Eidens,D., Futreal,P.A., Harshman,K., Tavtigian,S., Liu,Q., Cochran,C., Bennett,L.M., Ding,W. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
11. Lane,T.F., Deng,C., Elson,A., Lyu,M.S., Kozak,C.A. and Leder,P. (1995) Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev., 9, 2712-2722.
12. ElShamy,W.M. and Livingston,D.M. (2004) Identification of BRCA1-IRIS, a BRCA1 locus product. Nature Cell Biol., 6, 954-967.
13. Wilson,C.A., Payton,M.N., Elliott,G.S., Buaas,F.W., Cajulis,E.E., Grosshans,D., Ramos,L., Reese,D.M., Slamon,D.J. and Calzone,F.J. (1997) Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene, 14, 1-16.
14. Thakur,S., Zhang,H.B., Peng,Y., Le,H., Carroll,B., Ward,T., Yao,J., Farid,L.M., Couch,F.J., Wilson,R.B. et al. (1997) Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell Biol., 17, 444-452.
15. 2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell, 3, 389-395.
16. Paterson,J.W. (1998) BRCA1: A review of structure and putative functions. Dis. Markers, 13, 261-274.
17. Deng,C.X. and Brodie,S.G. (2000) Roles of BRCA1 and its interacting proteins. Bioessays, 22, 728-737.
18. Venkitaraman,A.R. (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108, 171-182.
19. Deng,C.X. (2002) Tumor formation in Brca1 conditional mutant mice. Environ. Mol. Mutagen., 39, 171-177.
20. Brodie,S.G. and Deng,C.X. (2001) BRCA1-associated tumorigenesis: What have we learned from knockout mice? Trends Genet., 17, S18-S22.
21. Deng,C.X. (2001) Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat. Res., 477, 183-189.
22. Kinzler,K.W. and Vogelstein,B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761-763.
23. Tirkkonen,M., Johannsson,O., Agnarsson,B.A., Olsson,H., Ingvarsson,S., Karhu,R., Tanner,M., Isola,J., Barkardottir,R.B., Borg,A. et al. (1997) Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57, 1222-1227.
24. Tomlinson,G.E., Chen,T.T., Stastny,V.A., Virmani,A.K., Spillman,M.A., Tonk,V., Blum,J.L., Schneider,N.R., Wistuba,II., Shay,J.W. et al. (1998) Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res., 58, 3237-3242.
25. Xu,X., Wagner,K.U., Larson,D., Weaver,Z., Li,C., Ried,T., Hennighausen,L., Wynshaw-Boris,A. and Deng,C.X. (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genet., 22, 37-43.
26. Weaver,Z., Montagna,C., Xu,X., Howard,T., Gadina,M., Brodie,S.G., Deng,C.X. and Ried,T. (2002) Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene, 21, 5097-5107.
27. Brodie,S.G., Xu,X., Qiao,W., Li,W.M., Cao,L. and Deng,C.X. (2001) Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene, 20, 7514-7523.
28. Shen,S.X., Weaver,Z., Xu,X., Li,C., Weinstein,M., Chen,L., Guan,X.Y., Ried,T. and Deng,C.X. (1998) A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene, 17, 3115-3124.
29. Xu,X., Qiao,W., Linke,S.P., Cao,L., Li,W.M., Furth,P.A., Harris,C.C. and Deng,C.X. (2001) Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nature Genet., 28, 266-271.
30. Silver,D.P. and Livingston,D.M. (2001) Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol. Cell, 8, 233-243.
31. Wang,R.H., Yu,H. and Deng,C.X. (2004) A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proc. Natl Acad. Sci. USA, 101, 17108-17113.
32. Deng,C.X. and Scott,F. (2000) Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene, 19, 1059-1064.
33. Deng,C.X. (2002) Roles of BRCA1 in centrosome duplication. Oncogene, 21, 6222-6227.
34. Deng,C.X. and Wang,R.H. (2003) Roles of BRCA1 in DNA damage repair: A link between development and cancer. Hum. Mol. Genet., 12, R113-R123.
35. Henderson,B.R. (2005) Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking. Bioessays, 27, 884-893.
36. Cantor,S.B. and Andreassen,P.R. (2006) Assessing the link between BACH1 and BRCA1 in the FA pathway. Cell Cycle, 5, 164-167.
37. Baer,R. and Ludwig,T. (2002) The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev., 12, 86-91.
38. Elledge,S.J. (1996) Cell cycle checkpoints: Preventing an identity crisis. Science, 274, 1664-1672.
39. Kastan,M.B. and Bartek,J. (2004) Cell-cycle checkpoints and cancer. Nature, 432, 316-323.
40. Kops,G.J., Weaver,B.A. and Cleveland,D.W. (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Rev. Cancer, 5, 773-785.
41. Vaughn,J.P., Davis,P.L., Jarboe,M.D., Huper,G., Evans,A.C., Wiseman,R.W., Berchuck,A., Iglehart,J.D., Futreal,P.A. and Marks,J.R. (1996) BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ., 7, 711-715.
42. Ruffner,H. and Verma,I.M. (1997) BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl Acad. Sci. USA, 94, 7138-7143.
43. Thompson,M.E., Jensen,R.A., Obermiller,P.S., Page,D.L. and Holt,J.T. (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet., 9, 444-450.
44. Holt,J.T., Thompson,M.E., Szabo,C., Robinson-Benion,C., Arteaga,C.L., King,M.C. and Jensen,R.A. (1996) Growth retardation and tumour inhibition by BRCA1. Nature Genet., 12, 298-302.
45. Aprelikova,O.N., Fang,B.S., Meissner,E.G., Cotter,S., Campbell,M., Kuthiala,A., Bessho,M., Jensen,R.A. and Liu,E.T. (1999) BRCA1-associated growth arrest is RB-dependent. Proc. Natl Acad. Sci. USA, 96, 11866-11871.
46. Yarden,R.I. and Brody,L.C. (1999) BRCA1 interacts with components of the histone deacetylase complex. Proc. Natl Acad. Sci. USA, 96, 4983-4988.
47. el-Deiry,W.S., Tokino,T., Velculescu,V.E., Levy,D.B., Parsons,R., Trent,J.M., Lin,D., Mercer,W.E., Kinzler,K.W. and Vogelstein,B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
48. 1 cyclin-dependent kinases. Cell, 75, 805-816.
49. 1 checkpoint control. Cell, 82, 675-684.
50. Somasundaram,K., Zhang,H., Zeng,Y.X., Houvras,Y., Peng,Y., Wu,G.S., Licht,J.D., Weber,B.L. and El-Deiry,W.S. (1997) Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature, 389, 187-190.
51. Wu,L.C., Wang,Z.W., Tsan,J.T., Spillman,M.A., Phung,A., Xu,X.L., Yang,M.C., Hwang,L.Y., Bowcock,A.M. and Baer,R. (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genet., 14, 430-440.
52. 1/S arrest following ionizing radiation-induced DNA damage. J. Biol. Chem., 279, 31251-31258.
53. Hakem,R., de la Pompa,J.L., Elia,A., Potter,J. and Mak,T.W. (1997) Partial rescue of Brca1 (5-6) early embryonic lethality by p53 orp21 null mutation. Nature Genet., 16, 298-302.
54. Ludwig,T., Chapman,D.L., Papaioannou,V.E. and Efstratiadis,A. (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev., 11, 1226-1241.
55. Donehower,L.A. and Bradley,A. (1993) The tumor suppressor p53. Biochim. Biophys. Acta., 1155, 181-205.
56. 1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment. Int. J. Radiat. Oncol. Biol. Phys., 58, 470-478.
57. Turner,J.M., Aprelikova,O., Xu,X., Wang,R., Kim,S., Chandramouli,G.V., Barrett,J.C., Burgoyne,P.S. and Deng,C.X. (2004) BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation. Curr. Biol., 14, 2135-2142.
58. Shiloh,Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. pp. 635-662.
59. Scully,R., Ganesan,S., Vlasakova,K., Chen,J., Socolovsky,M. and Livingston,D.M. (1999) Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell, 4, 1093-1099.
60. Xu,B., Kim,S. and Kastan,M.B. (2001) Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell Biol., 21, 3445-3450.
61. Xu,B., O'Donnell,A.H., Kim,S.T. and Kastan,M.B. (2002) Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation. Cancer Res., 62, 4588-4591.
62. Cortez,D., Wang,Y., Qin,J. and Elledge,S.J. (1999) Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science, 286, 1162-1166.
63. Okada,S. and Ouchi,T. (2003) Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization. J. Biol. Chem., 278, 2015-2020.
64. Tibbetts,R.S., Cortez,D., Brumbaugh,K.M., Scully,R., Livingston,D., Elledge,S.J. and Abraham,R.T. (2000) Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev., 14, 2989-3002.
65. Stewart,G.S., Wang,B., Bignell,C.R., Taylor,A.M. and Elledge,S.J. (2003) MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature, 421, 961-966.
66. Durant,S.T. and Nickoloff,J.A. (2005) Good timing in the cell cycle for precise DNA repair by BRCA1. Cell Cycle, 4, 1216-1222.
67. 2/M checkpoint by activating Chk1 kinase upon DNA damage. Nature Genet., 30, 285-289.
68. Hutchins,J.R. and Clarke,P.R. (2004) Many fingers on the mitotic trigger: Post-translational regulation of the Cdc25C phosphatase. Cell Cycle, 3, 41-45.
69. Muslin,A.J. and Xing,H. (2000) 14-3-3 proteins: Regulation of subcellular localization by molecular interference. Cell Signal, 12, 703-709.
70. Sancar,A., Lindsey-Boltz,L.A., Unsal-Kacmaz,K. and Linn,S. (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem., 73, 39-85.
71. Lee,J.S., Collins,K.M., Brown,A.L., Lee,C.H. and Chung,J.H. (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature, 404, 201-204.
72. Kim,S.S., Cao,L., Li,C., Xu,X., Huber,L.J., Chodosh,L.A. and Deng,C.X. (2004) Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1. Mol. Cell Biol., 24, 9498-9507.
73. Meraldi,P., Honda,R. and Nigg,E.A. (2004) Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev., 14, 29-36.
74. Katayama,H., Brinkley,W.R. and Sen,S. (2003) The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev., 22, 451-464.
75. Ducat,D. and Zheng,Y. (2004) Aurora kinases in spindle assembly and chromosome segregation. Exp. Cell Res., 301, 60-67.
76. Crane,R., Gadea,B., Littlepage,L., Wu,H. and Ruderman,J.V. (2004) Aurora A, meiosis and mitosis. Biol. Cell, 96, 215-229.
77. Zhou,H., Kuang,J., Zhong,L., Kuo,W.L., Gray,J.W., Sahin,A., Brinkley,B.R. and Sen,S. (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet., 20, 189-193.
78. Giet,R., Petretti,C. and Prigent,C. (2005) Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol., 15, 241-250.
79. Bischoff, J.R., Anderson,L., Zhu,Y., Mossie,K., Ng,L., Souza,B., Schryver,B., Flanagan,P., Clairvoyant,F., Ginther,C. et al. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J., 17, 3052-3065.
80. Hu,W., Kavanagh,J.J., Deaver,M., Johnston,D.A., Freedman,R.S., Verschraegen,C.F. and Sen,S. (2005) Frequent overexpression of STK15/ Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol. Res., 15, 49-57.
81. Kamada,K., Yamada,Y., Hirao,T., Fujimoto,H., Takahama,Y., Ueno,M., Takayama,T., Naito,A., Hirao,S. and Nakajima,Y. (2004) Amplification/ overexpression of Aurora-A in human gastric carcinoma: Potential role in differentiated type gastric carcinogenesis. Oncol. Rep., 12, 593-599.
82. Tanaka,E., Hashimoto,Y., Ito,T., Okumura,T., Kan,T., Watanabe,G., Imamura,M., Inazawa,J. and Shimada,Y. (2005) The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin. Cancer Res., 11, 1827-1834.
83. Tanaka,T., Kimura,M., Matsunaga,K., Fukada,D., Mori,H. and Okano,Y. (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res., 59, 2041-2044.
84. 2 to M transition. J. Biol. Chem., 279, 19643-19648.
85. Zhang,D., Hirota,T., Marumoto,T., Shimizu,M., Kunitoku,N., Sasayama,T., Arima,Y., Feng,L., Suzuki,M., Takeya,M. et al. (2004) Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene, 23, 8720-8730.
86. Gatei,M., Zhou,B.B., Hobson,K., Scott,S., Young,D. and Khanna,K.K. (2001) Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J. Biol. Chem., 276, 17276-17280.
87. Lin,S.Y. and Elledge,S.J. (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell, 113, 881-889.
88. Jackson,A.P., Eastwood,H., Bell,S.M., Adu,J., Toomes,C., Carr,I.M., Roberts,E., Hampshire,D.J., Crow,Y.J., Mighell,A.J. et al. (2002) Identification of microcephalin, a protein implicated in determining the size of the human brain. Am. J. Hum. Genet., 71, 136-142.
89. Lin,S.Y., Rai,R., Li,K., Xu,Z.X. and Elledge,S.J. (2005) BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc. Natl Acad. Sci. USA, 102, 15105-15109.
90. Peters,J.M. (2002) The anaphase-promoting complex: Proteolysis in mitosis and beyond. Mol. Cell, 9, 931-943.
91. Cleveland,D.W., Mao,Y. and Sullivan,K.F. (2003) Centromeres and kinetochores: From epigenetics to mitotic checkpoint signaling. Cell, 112, 407-421.
92. Yu,H. (2002) Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin. Cell Biol., 14, 706-714.
93. Amon,A. (1999) The spindle checkpoint. Curr. Opin. Genet. Dev., 9, 69-75.
94. Fang,G. (2002) Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex. Mol. Biol. Cell, 13, 755-766.
95. Sudakin,V., Chan,G.K. and Yen,T.J. (2001) Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol., 154, 925-936.
96. Tang,Z., Bharadwaj,R., Li,B. and Yu,H. (2001) Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev. Cell, 1, 227-237.
97. Gorbsky,G.J., Chen,R.H. and Murray,A.W. (1998) Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase. J. Cell Biol., 141, 1193-1205.
98. Dobles,M., Liberal,V., Scott,M.L., Benezra,R. and Sorger,P.K. (2000) Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell, 101, 635-645.
99. Michel,L.S., Liberal,V., Chatterjee,A., Kirchwegger,R., Pasche,B., Gerald,W., Dobles,M., Sorger,P.K., Murty,V.V. and Benezra,R. (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature, 409, 355-359.
100. Nicklas,R.B. (1997) How cells get the right chromosomes. Science, 275, 632-637.
101. Wassmann,K., Liberal,V. and Benezra,R. (2003) Mad2 phosphorylation regulates its association with Mad1 and the APC/C. EMBO J., 22, 797-806.
102. Harkin,D.P., Bean,J.M., Miklos,D., Song,Y.H., Truong,V.B., Englert,C., Christians,F.C., Ellisen,L.W., Maheswaran,S., Oliner,J.D. et al. (1999) Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell, 97, 575-586.
103. Bae,I., Rih,J.K., Kim,H.J., Kang,H.J., Haddad,B., Kirilyuk,A., Fan,S., Avantaggiati,M.L. and Rosen,E.M. (2005) BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle, 4, 1641-1666.
104. Lowe,S.W., Cepero,E. and Evan,G. (2004) Intrinsic tumour suppression. Nature, 432, 307-315.
105. Chen,Z., Trotman,L.C., Shaffer,D., Lin,H.K., Dotan,Z.A., Niki,M., Koutcher,J.A., Scher,H.I., Ludwig,T., Gerald,W. et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature, 436, 725-730.
106. Bartkova,J., Horejsi,Z., Koed,K., Kramer,A., Tort,F., Zieger,K., Guldberg,P., Sehested,M., Nesland,J.M., Lukas,C. et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature, 434, 864-870.
107. Gorgoulis,V.G., Vassiliou,L.V., Karakaidos,P., Zacharatos,P., Kotsinas,A., Liloglou,T., Venere,M., Ditullio,R.A.,Jr, Kastrinakis,N.G., Levy,B. et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 434, 907-913.
108. Cao,L., Li,W., Kim,S., Brodie,S.G. and Deng,C.X. (2003) Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev., 17, 201-213.
109. Schuyer,M. and Berns,E.M. (1999) Is TP53 dysfunction required for BRCA1-associated carcinogenesis? Mol. Cell Endocrinol., 155, 143-152.
110. McPherson,J.P., Lemmers,B., Hirao,A., Hakem,A., Abraham,J., Migon,E., Matysiak-Zablocki,E., Tamblyn,L., Sanchez-Sweatman,O., Khokha,R. et al. (2004) Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev., 18, 1144-1153.
111. Ishitobi,M., Miyoshi,Y., Hasegawa,S., Egawa,C., Tamaki,Y., Monden,M. and Noguchi,S. (2003) Mutational analysis of BARD1 in familial breast cancer patients in Japan. Cancer Lett., 200, 1-7.
112. Ghimenti,C., Sensi,E., Presciuttini,S., Brunetti,I.M., Conte,P., Bevilacqua,G. and Caligo,M.A. (2002) Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes Chromosomes Cancer, 33, 235-242.
113. Senkus-Konefka,E., Konefka,T. and Jassem,J. (2004) The effects of tamoxifen on the female genital tract. Cancer Treat. Rev., 30, 291-301.
114. Simeone,A.M., Deng,C.X., Kelloff,G.J., Steele,V.E., Johnson,M.M. and Tari,A.M. (2005) N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells. Carcinogenesis, 26, 1000-1007.
115. Farmer,H., McCabe,N., Lord,C.J., Tutt,A.N., Johnson,D.A., Richardson,T.B., Santarosa,M., Dillon,K.J., Hickson,I., Knights,C. et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 434, 917-921.
116. Bryant,H.E., Schultz,N., Thomas,H.D., Parker,K.M., Flower,D., Lopez,E., Kyle,S., Meuth,M., Curtin,N.J. and Helleday,T. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature, 434, 913-917.